FI870394A - Kinonderivat, deras framstaellning och anvaendning. - Google Patents
Kinonderivat, deras framstaellning och anvaendning. Download PDFInfo
- Publication number
- FI870394A FI870394A FI870394A FI870394A FI870394A FI 870394 A FI870394 A FI 870394A FI 870394 A FI870394 A FI 870394A FI 870394 A FI870394 A FI 870394A FI 870394 A FI870394 A FI 870394A
- Authority
- FI
- Finland
- Prior art keywords
- sup
- agents
- sub
- hydrogen atom
- group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/46—Oxygen atoms
- C07D213/50—Ketonic radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/55—Acids; Esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- H—ELECTRICITY
- H03—ELECTRONIC CIRCUITRY
- H03C—MODULATION
- H03C1/00—Amplitude modulation
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Immunology (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Suspension Of Electric Lines Or Cables (AREA)
- Lubricants (AREA)
- Debugging And Monitoring (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1954786 | 1986-01-30 | ||
JP9416886 | 1986-04-23 |
Publications (2)
Publication Number | Publication Date |
---|---|
FI870394A0 FI870394A0 (fi) | 1987-01-29 |
FI870394A true FI870394A (fi) | 1987-07-31 |
Family
ID=26356389
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI870394A FI870394A (fi) | 1986-01-30 | 1987-01-29 | Kinonderivat, deras framstaellning och anvaendning. |
Country Status (16)
Country | Link |
---|---|
US (3) | US4851413A (pt) |
EP (1) | EP0234729B1 (pt) |
JP (1) | JPH0830061B2 (pt) |
KR (1) | KR870007119A (pt) |
CN (1) | CN87100723A (pt) |
AT (1) | ATE70828T1 (pt) |
AU (1) | AU601657B2 (pt) |
CA (1) | CA1285562C (pt) |
DE (1) | DE3775427D1 (pt) |
DK (1) | DK28687A (pt) |
FI (1) | FI870394A (pt) |
HU (1) | HU198908B (pt) |
IL (1) | IL81264A (pt) |
NO (1) | NO870379L (pt) |
PT (1) | PT84217B (pt) |
SU (1) | SU1676442A3 (pt) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE74269T1 (de) * | 1987-07-29 | 1992-04-15 | Takeda Chemical Industries Ltd | Zellproliferationsinhibitor. |
JPH08768B2 (ja) * | 1989-08-24 | 1996-01-10 | 武田薬品工業株式会社 | 神経成長因子分泌誘導剤 |
IE920595A1 (en) * | 1991-03-11 | 1992-09-23 | Eisai Co Ltd | Quinone derivatives |
EP0560568A3 (en) * | 1992-03-13 | 1994-06-29 | Takeda Chemical Industries Ltd | Hydroquinone derivatives and intermediates for production thereof |
AU657413C (en) * | 1992-05-29 | 2007-05-03 | Otsuka Pharmaceutical Co., Ltd. | Thiazole derivatives for the release of superoxide radical |
US5639770A (en) * | 1992-05-29 | 1997-06-17 | Otsuka Pharmaceutical Co., Ltd. | Thiazole derivatives |
EP0774967A1 (en) * | 1994-08-12 | 1997-05-28 | Takeda Chemical Industries, Ltd. | Use of quinone and hydroquinone derivatives for the teatment of cachexia |
EP0719552A3 (en) * | 1994-12-26 | 1997-08-20 | Takeda Chemical Industries Ltd | Pharmaceutical composition containing a quinone derivative or the hydroquinone thereof for the treatment of dermatitis |
US6664255B1 (en) | 1999-05-19 | 2003-12-16 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade |
US6867217B1 (en) | 1999-05-19 | 2005-03-15 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade |
US6458952B1 (en) * | 1999-05-19 | 2002-10-01 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl uracils useful for selective inhibition of the coagulation cascade |
US6716838B1 (en) | 1999-05-19 | 2004-04-06 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl uracils as anticoagulative agents |
US6750342B1 (en) | 1999-05-19 | 2004-06-15 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade |
US6906068B1 (en) | 1999-05-19 | 2005-06-14 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl 1,2,4 - triazinones useful as anticoagulants |
US6653316B1 (en) * | 1999-05-19 | 2003-11-25 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade |
US6908919B2 (en) * | 1999-05-19 | 2005-06-21 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade |
US7015230B1 (en) | 1999-05-19 | 2006-03-21 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl uracils useful for selective inhibition of the coagulation cascade |
AU775373B2 (en) | 1999-10-01 | 2004-07-29 | Immunogen, Inc. | Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
US6660885B2 (en) | 2000-03-13 | 2003-12-09 | Pharmacia Corporation | Polycyclic aryl and heteroaryl substituted benzenes useful for selective inhibition of the coagulation cascade |
AU2001249870A1 (en) * | 2000-04-05 | 2001-10-23 | Pharmacia Corporation | Polycyclic aryl and heteroaryl substituted 4-pyrones useful for selective inhibition of the coagulation cascade |
US6693121B2 (en) | 2000-04-05 | 2004-02-17 | Pharmacia Corporation | Polycyclic aryl and heteroaryl substituted 4-pyridones useful for selective inhibition of the coagulation cascade |
WO2001079155A2 (en) * | 2000-04-17 | 2001-10-25 | Pharmacia Corporation | Polycyclic aryl and heteroaryl substituted 1,4-quinones useful for selective inhibition of the coagulation cascade |
US7119094B1 (en) | 2000-11-20 | 2006-10-10 | Warner-Lambert Company | Substituted polycyclic aryl and heteroarpyl pyrazinones useful for selective inhibition of the coagulation cascade |
US7015223B1 (en) | 2000-11-20 | 2006-03-21 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl 1,2,4-triazinones useful for selective inhibition of the coagulation cascade |
WO2002042272A2 (en) * | 2000-11-20 | 2002-05-30 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade |
US20030236257A1 (en) * | 2001-04-04 | 2003-12-25 | South Michael S. | Polycyclic aryl and heteroaryl substituted 4-pyridones useful for selective inhibition of the cogulation cascade |
MXPA04003163A (es) * | 2001-10-03 | 2004-07-08 | Pharmacia Corp | Compuestos heterociclicos de 6 elementos utiles para inhibicion selectiva de la casdada de coagulacion. |
US20040082585A1 (en) * | 2001-10-03 | 2004-04-29 | Pharmacia Corporation | Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade |
WO2003029224A1 (en) * | 2001-10-03 | 2003-04-10 | Pharmacia Corporation | 6-membered unsaturated heterocyclic compounds useful for selective inhibition of the coagulation cascade |
WO2003093242A2 (en) * | 2001-10-03 | 2003-11-13 | Pharmacia Corporation | Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade |
WO2003041682A2 (en) * | 2001-11-13 | 2003-05-22 | Celator Technologies, Inc. | Lipid carrier compositions and methods for improved drug retention |
US20040068113A1 (en) * | 2001-11-20 | 2004-04-08 | South Michael S. | Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade |
US6653311B1 (en) | 2002-06-25 | 2003-11-25 | Board Of Supervisors Of Louisiana State University | 5-lipoxygenase inhibitors: (2-azinylamino) quinone derivatives |
WO2009052376A1 (en) | 2007-10-18 | 2009-04-23 | Musc Foundation For Research Development | Methods for the diagnosis of genitourinary cancer |
US8263094B2 (en) * | 2008-09-23 | 2012-09-11 | Eastman Chemical Company | Esters of 4,5-disubstituted-oxy-2-methyl-3,6-dioxo-cyclohexa-1,4-dienyl alkyl acids and preparation thereof |
EP2505583A1 (en) * | 2011-03-29 | 2012-10-03 | Centre National de la Recherche Scientifique | Total synthesis of redox-active 1.4-naphthoquinones and their metabolites and their therapeutic use as antimalarial and schistomicidal agents |
JP2016515526A (ja) * | 2013-03-15 | 2016-05-30 | エジソン ファーマシューティカルズ, インコーポレイテッド | 酸化ストレス障害の処置のためのアルキル−ヘテロアリール置換されたキノン誘導体 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3929880A (en) * | 1971-08-21 | 1975-12-30 | Merck Patent Gmbh | Process for the preparation of oxocarboxylic acid amides and oxocarboxylic acids |
US4201588A (en) * | 1974-04-15 | 1980-05-06 | Eastman Kodak Company | Radiation sensitive co(III)complex photoreduction element with image recording layer |
US4271083A (en) * | 1974-05-02 | 1981-06-02 | Takeda Chemical Industries, Ltd. | 6-Hydroxy-1,4-benzoquinone compounds |
DE2862340D1 (en) * | 1978-02-01 | 1983-11-24 | Wellcome Found | Imidazole derivatives and salts thereof, their synthesis, and pharmaceutical formulations thereof |
EP0004727B1 (en) * | 1978-04-12 | 1981-08-12 | Imperial Chemical Industries Plc | Blood platelet aggregation inhibitory pyridine derivatives, pharmaceutical compositions thereof, and processes for their manufacture |
US4393075A (en) * | 1980-04-14 | 1983-07-12 | Takeda Chemical Industries, Ltd. | Quinone compounds and their use in suppressing the production of SRS-A in mammals |
JPS58177934A (ja) * | 1982-04-13 | 1983-10-18 | Takeda Chem Ind Ltd | ベンゾキノン誘導体 |
JPS5910541A (ja) * | 1982-07-09 | 1984-01-20 | Takeda Chem Ind Ltd | キノン化合物 |
MX9203040A (es) * | 1984-08-01 | 1992-07-31 | Takeda Chemical Industries Ltd | Derivados de quinona y composicion farmaceutica que los contiene. |
-
1987
- 1987-01-14 IL IL81264A patent/IL81264A/xx not_active IP Right Cessation
- 1987-01-15 CA CA000527381A patent/CA1285562C/en not_active Expired - Lifetime
- 1987-01-16 US US07/004,138 patent/US4851413A/en not_active Expired - Lifetime
- 1987-01-20 DK DK028687A patent/DK28687A/da not_active Application Discontinuation
- 1987-01-22 AU AU67933/87A patent/AU601657B2/en not_active Ceased
- 1987-01-23 DE DE8787300581T patent/DE3775427D1/de not_active Expired - Fee Related
- 1987-01-23 EP EP19870300581 patent/EP0234729B1/en not_active Expired - Lifetime
- 1987-01-23 AT AT87300581T patent/ATE70828T1/de not_active IP Right Cessation
- 1987-01-27 KR KR870000637A patent/KR870007119A/ko not_active IP Right Cessation
- 1987-01-29 NO NO870379A patent/NO870379L/no unknown
- 1987-01-29 FI FI870394A patent/FI870394A/fi not_active Application Discontinuation
- 1987-01-29 PT PT84217A patent/PT84217B/pt not_active IP Right Cessation
- 1987-01-29 SU SU874028912A patent/SU1676442A3/ru active
- 1987-01-30 JP JP62021516A patent/JPH0830061B2/ja not_active Expired - Lifetime
- 1987-01-30 CN CN198787100723A patent/CN87100723A/zh active Pending
- 1987-01-30 HU HU87310A patent/HU198908B/hu not_active IP Right Cessation
-
1989
- 1989-04-25 US US07/343,142 patent/US4985447A/en not_active Expired - Fee Related
-
1990
- 1990-10-19 US US07/600,149 patent/US5106858A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
PT84217A (en) | 1987-02-01 |
JPH0830061B2 (ja) | 1996-03-27 |
FI870394A0 (fi) | 1987-01-29 |
HU198908B (en) | 1989-12-28 |
DK28687A (da) | 1987-07-31 |
SU1676442A3 (ru) | 1991-09-07 |
EP0234729A2 (en) | 1987-09-02 |
KR870007119A (ko) | 1987-08-14 |
US5106858A (en) | 1992-04-21 |
IL81264A0 (en) | 1987-08-31 |
IL81264A (en) | 1990-11-05 |
CA1285562C (en) | 1991-07-02 |
EP0234729B1 (en) | 1991-12-27 |
PT84217B (pt) | 1989-09-14 |
DK28687D0 (da) | 1987-01-20 |
AU6793387A (en) | 1987-08-06 |
CN87100723A (zh) | 1987-09-16 |
ATE70828T1 (de) | 1992-01-15 |
EP0234729A3 (en) | 1988-01-27 |
NO870379L (no) | 1987-07-31 |
DE3775427D1 (de) | 1992-02-06 |
HUT44504A (en) | 1988-03-28 |
NO870379D0 (no) | 1987-01-29 |
US4985447A (en) | 1991-01-15 |
AU601657B2 (en) | 1990-09-13 |
JPS6345257A (ja) | 1988-02-26 |
US4851413A (en) | 1989-07-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI870394A (fi) | Kinonderivat, deras framstaellning och anvaendning. | |
ES8704870A1 (es) | Un procedimiento para preparar derivados de quiniona. | |
IL107185A0 (en) | 25-Carboxylic acid derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same | |
JPS6483010A (en) | Melanization inhibitory drug for external use | |
ES448394A1 (es) | Procedimiento para la obtencion de esteres de alcoxialquil- hidropiridina. | |
EP0342665A3 (en) | Physiologically active substance tan-931, its derivatives, their production and use | |
GB1453828A (en) | Fluoro-substituted thiaxanthene derivatives | |
ES8102563A1 (es) | Procedimiento para la preparacion de nuevas sustancias analogas de prostaciclina | |
YU45900B (sh) | Postupak za dobijanje n-oksid estara piridilkarbonske kiseline | |
EP0036218A3 (en) | Quinuclidinic esters and derivatives of phenoxycarboxylic acids, a process for the preparation thereof, and related pharmaceutical compositions | |
GB1321692A (en) | Dihydro-3-piperidyl-2 3h-furanone derivatives | |
IE43256L (en) | Tetrahydrofuroquinoline-7-carboxylic acid derivatives | |
JPS5246067A (en) | Reduction of optically active 5-oxo-2-pyrrolidinacetic acid esters | |
DE3469734D1 (en) | Biphenylylalkanoic acid derivatives, methods of preparation and pharmaceutical compositions therefrom | |
JPS51115481A (en) | Process for preparation of (3,4-dihydro-6-carbostyril)carboxylic and e ster derivatives | |
GB1510092A (en) | Derivatives of vincaminic acid hydrazide | |
ES8307782A1 (es) | Procedimiento para la preparacion de un nuevo derivado perteneciente a la familia de los 3-amino-1-heteroariloxi-2-propanoles. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Application withdrawn |
Owner name: TAKEDA CHEMICAL INDUSTRIES, LTD. |